Razer Faces FTC Backlash Over Mask Claims

At CES 2021, Razer unveiled a concept mask named Project Hazel, which garnered significant attention due to its striking design and RGB lighting effects. Subsequently named the “Razer Zephyr,” this product featured replaceable filters and officially went on sale for $99.99. At CES 2022, Razer introduced an upgraded version, the “Razer Zephyr Pro,” which added an amplifier feature and was priced at $149.99.

According to Notebookcheck, the United States Federal Trade Commission (FTC) has recently demanded that Razer compensate consumers. This action was prompted by the Razer Zephyr and Razer Zephyr Pro not meeting the N95 standard certification, a discrepancy significantly at odds with Razer’s promotional claims.

Razer advertised the Razer Zephyr and Razer Zephyr Pro as “N95-grade” respirators capable of blocking up to 99% of particles smaller than 0.3 microns. The masks feature a waterproof, scratch-resistant shell made from recycled plastic, detachable and rechargeable active ventilators, and a high bacterial filtration efficiency (BFE) smart pod that adjusts airflow to optimize breathability. They boast active air-cooling and regulation features, with embedded fans that can switch modes to prevent the accumulation of carbon dioxide inside the mask. A wireless fast-charging box uses germicidal UV light for sterilization. The transparent design allows others to see the wearer’s facial expressions and even read lips. If the user is in the dark, the mask’s internal lighting automatically activates, and it can be used in conjunction with Razer Chroma RGB lighting.

In fact, Razer did not submit the designs of the Razer Zephyr and Razer Zephyr Pro for regulatory approval. Since they were not tested, their effectiveness in preventing COVID-19 infection is uncertain. The FTC concluded that Razer’s misleading marketing compromised consumer health and proposed a settlement requiring Razer to fully refund all U.S. customers who purchased the Razer Zephyr and Razer Zephyr Pro, totaling $1.1 million. Additionally, the U.S. Food and Drug Administration (FDA) imposed a fine of $100,000 on Razer, along with specific conditions to prevent further unapproved and misleading promotions.

It is understood that Razer has also sold these products in other regions without obtaining the necessary local certifications, suggesting that similar penalties may follow.